The mechanism of inhibition of Ran-dependent nuclear transport by cellular ATP depletion

por Schwoebel, Eric D., Ho, Thai H., Moore, Mary Shannon
Publicado 2002

In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma

por Yang, Man, Hlady, Ryan A., Zhou, Dan, Ho, Thai H., Robertson, Keith D.
Publicado 2019

Cancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time

por Ali, Amama, Adams, Daniel L., Kasabwala, Dimpal M., Tang, Cha-Mei, Ho, Thai H.
Publicado 2023

Behavior of blood plasma glycan features in bladder cancer

por Ferdosi, Shadi, Ho, Thai H., Castle, Erik P., Stanton, Melissa L., Borges, Chad R.
Publicado 2018

Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia

por Zhang, Xiaodong, Saarinen, Alicia M, Hitosugi, Taro, Wang, Zhenghe, Wang, Liguo, Ho, Thai H, Liu, Jun
Publicado 2017

The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma

por Ho, Thai H, Liu, Xian-De, Huang, Yanqing, Warneke, Carla L, Johnson, Marcella M, Hoang, Anh, Tamboli, Pheroze, Wang, Fen, Jonasch, Eric
Publicado 2015

ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor–activated cancer

por Tang, Bo, Sun, Rui, Wang, Dejie, Sheng, Haoyue, Wei, Ting, Wang, Liguo, Zhang, Jun, Ho, Thai H., Yang, Lu, Wei, Qiang, Huang, Haojie
Publicado 2021

Detection of tumor-associated cells in cryopreserved peripheral blood mononuclear cell samples for retrospective analysis

por Zhu, Peixuan, Stanton, Melissa L., Castle, Erik P., Joseph, Richard W., Adams, Daniel L., Li, Shuhong, Amstutz, Platte, Tang, Cha-Mei, Ho, Thai H.
Publicado 2016

Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma

por Tiedemann, Rochelle L., Hlady, Ryan A., Hanavan, Paul D., Lake, Douglas F., Tibes, Raoul, Lee, Jeong-Heon, Choi, Jeong-Hyeon, Ho, Thai H., Robertson, Keith D.
Publicado 2015

8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness

por Eckel-Passow, Jeanette E., Yan, Huihuang, Kosel, Matthew L., Serie, Daniel, Decker, Paul A., Jenkins, Robert B., Costello, Brian, Leibovich, Bradley, Ho, Thai H., Parker, Alexander
Publicado 2020

Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors

por Blank, Christian U., Wong, Deborah J., Ho, Thai H., Bauer, Todd M., Lee, Carrie B., Bene-Tchaleu, Fabiola, Zhu, Jing, Zhang, Xiaosong, Cha, Edward, Sznol, Mario
Publicado 2021

Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines

por Hanavan, Paul D., Borges, Chad R., Katchman, Benjamin A., Faigel, Douglas O., Ho, Thai H., Ma, Chen-Ting, Sergienko, Eduard A., Meurice, Nathalie, Petit, Joachim L., Lake, Douglas F.
Publicado 2015

Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma

por Eckel‐Passow, Jeanette E., Ho, Thai H., Serie, Daniel J., Cheville, John C., Houston Thompson, R., Costello, Brian A., Dong, Haidong, Kwon, Eugene D., Leibovich, Bradley C., Parker, Alexander S.
Publicado 2019

Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome

por El Khoury, Louis Y., Pan, Xiaoyu, Hlady, Ryan A., Wagner, Ryan T., Shaikh, Shafiq, Wang, Liguo, Humphreys, Mitchell R., Castle, Erik P., Stanton, Melissa L., Ho, Thai H., Robertson, Keith D.
Publicado 2023

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor

por Eckel-Passow, Jeanette E., Serie, Daniel J., Cheville, John C., Ho, Thai H., Kapur, Payal, Brugarolas, James, Thompson, R. Houston, Leibovich, Bradley C., Kwon, Eugene D., Joseph, Richard W., Parker, Alexander S.
Publicado 2017

Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach

por Sarkar, Suryadipto, Min, Kong, Ikram, Waleed, Tatton, Ryan W., Riaz, Irbaz B., Silva, Alvin C., Bryce, Alan H., Moore, Cassandra, Ho, Thai H., Sonpavde, Guru, Abdul-Muhsin, Haidar M., Singh, Parminder, Wu, Teresa
Publicado 2023

Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death

por Ho, Thai H., Kapur, Payal, Joseph, Richard W., Serie, Daniel J., Eckel-Passow, Jeanette E., Tong, Pan, Wang, Jing, Castle, Erik P., Stanton, Melissa L., Cheville, John C., Jonasch, Eric, Brugarolas, James, Parker, Alexander S.
Publicado 2015

Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer

por El Khoury, Louis Y., Fu, Shuang, Hlady, Ryan A., Wagner, Ryan T., Wang, Liguo, Eckel-Passow, Jeanette E., Castle, Erik P., Stanton, Melissa L., Thompson, R. Houston, Parker, Alexander S., Ho, Thai H., Robertson, Keith D.
Publicado 2021

Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects

por Simon, Jeremy M., Hacker, Kathryn E., Singh, Darshan, Brannon, A. Rose, Parker, Joel S., Weiser, Matthew, Ho, Thai H., Kuan, Pei-Fen, Jonasch, Eric, Furey, Terrence S., Prins, Jan F., Lieb, Jason D., Rathmell, W. Kimryn, Davis, Ian J.
Publicado 2014

Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer

por Velez, Miguel Gonzalez, Kosiorek, Heidi E., Egan, Jan B., McNatty, Andrea L., Riaz, Irbaz B., Hwang, Steven R., Stewart, Glenn A., Ho, Thai H., Moore, Cassandra N., Singh, Parminder, Sharpsten, Renee K., Costello, Brian A., Bryce, Alan H.
Publicado 2021